Matthew Peters is a versatile litigator and advocate who represents leading global companies and individual executives in complex commercial litigation, with an emphasis on securities litigation.
Matthew focuses his practice on counseling clients in high-stakes and complex matters, including:
Matthew brings clients a unique global perspective based on extensive experience studying and working in China, and a previous career with the Central Intelligence Agency.
He maintains an active pro bono practice, representing victims of human trafficking and children in need of legal assistance.
While in law school, Matthew served as an editor on the Duke Law Journal.
Matthew's experience includes representing:
Latham litigators were recognized for securing a complete dismissal of all claims for Carvana in a stockholder derivative complaint, and for securing a dismissal in full for vaccine maker Sinovac Biotech in a shareholder class action.
Latham team recognized for knocking out securities class action on behalf of client Carvana.